A prospective long-term multi-center observational study for the timely update of optimal social medical system and individualized treatment strategy in patients with acute coronary syndrome: REVEIL-ACS registry

A prospective long-term multi-center observational study for the timely update of optimal social medical system and individualized treatment strategy in patients with acute coronary syndrome: REVEIL-ACS registry - REVEIL-ACS registry

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000053536

Enrollment

5000

Registered

2024-02-16

Start date

2024-02-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute coronary syndrome

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed with ACS who visited (or were admitted to) the hospitals between July 2023 and March 2028 and who meet the following eligibility criteria and do not meet any of the exclusion criteria. Patients indicated for emergency coronary angiography due to the diagnosis of acute coronary syndrome (unstable angina, ST-segment elevation myocardial infarction, and non-ST-segment elevation myocardial infarction) Patients aged 18 years or older Patients who can be followed up regularly once a year

Exclusion criteria

Exclusion criteria: Patients who declared non-participation in the study Patients who are regarded as inappropriate to participate in the study by the investigator or subinvestigator

Design outcomes

Primary

Measure	Time frame
Primary endpoint: Major adverse cardiovascular events at 3 years (MACCE: Composite endpoint of all deaths, myocardial infarction, repeat revascularization, stroke, systemic embolism, and heart failure rehospitalization).	—

Secondary

Measure	Time frame
Incidence of each primary endpoint over time Incidence of the following clinical outcomes over time 1.Death 2.Myocardial infarction 3.Stent thrombosis 4.Repeat revascularization 5.Emergency revascularization 6.Bleeding events 7.Stroke 8.Systemic embolism 9.Progression to ischemic cardiomyopathy (ICM) 10.Heart failure hospitalization Incidence of all other endpoints defined in ARC-2	—

Countries

Japan

Contacts

Public ContactYohei Sotomi

Osaka University Graduate School of Medicine Department of Cardiovascular Medicine

sotomi.yohei.med@osaka-u.ac.jp06-6879-3631

Outcome results